Devices & Diagnostics Letter

Oct. 8, 2012 | Vol. 39 No. 40

Companion Diagnostics: Recognizing and Overcoming the Challenges

BOSTON — Companion diagnostics that can be used to personalize medicine are no longer a pipe dream, but challenges to moving them to market remain, according to a Tuesday panel of experts at the AdvaMed 2012 conference.

This article is viewable by subscribers only. To view this article, please select an option below.

Subscribe
Print This Page
RSS
Free Trial
Archives
Sample PDF

FDA Approves First Companion Dx for EGFR Mutations in NSCLC FDA Misses UDI Final Rule Deadline; Hamburg Asked for Update FDA Warns Chinese Devicemaker, Citing Lack of CAPA Triggers Speech Therapy Devicemakers Warned Over Quality System Shortfalls

Home
Advertising/Sponsorships
About Us
Contact Us
Site Map
Privacy Policy

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.